{"id":"https://openalex.org/W2552801722","doi":"https://doi.org/10.1016/j.ijpharm.2016.07.053","title":"Regulatory aspects in the pharmaceutical development of nanoparticle drug delivery systems designed to cross the intestinal epithelium and M-cells","display_name":"Regulatory aspects in the pharmaceutical development of nanoparticle drug delivery systems designed to cross the intestinal epithelium and M-cells","alternate_titles":[],"publication_year":2016,"publication_date":"2016-11-01","ids":{"openalex":"https://openalex.org/W2552801722","doi":"https://doi.org/10.1016/j.ijpharm.2016.07.053","mag":"2552801722","pmid":"https://pubmed.ncbi.nlm.nih.gov/27863658"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2016.07.053","doi":"https://doi.org/10.1016/j.ijpharm.2016.07.053","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2016.07.053","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2552801722"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101927551","display_name":"Nasir Hussain","orcid":"https://orcid.org/0000-0002-4167-6846","observed_orcids":["https://orcid.org/0000-0002-4167-6846"]},"institutions":[{"id":"https://openalex.org/I4405282191","display_name":"Medicines and Healthcare products Regulatory Agency","ror":"https://ror.org/05fan1e59","country_code":"GB","type":"government","lineage":["https://openalex.org/I4405282191"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nasir Hussain","raw_affiliation_strings":["Medicines and Healthcare Products Regulatory Agency, Paediatric Unit, Special Populations Group, Vigilance and Risk Management of Medicines Division, 151 Buckingham Palace Road, London, SW1W 9SZ, United Kingdom. Electronic address: nasir.hussain@mhra.gsi.gov.uk","Medicines and Healthcare Products Regulatory Agency, Paediatric Unit, Special Populations Group, Vigilance and Risk Management of Medicines Division, 151 Buckingham Palace Road, London, SW1W 9SZ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines and Healthcare Products Regulatory Agency, Paediatric Unit, Special Populations Group, Vigilance and Risk Management of Medicines Division, 151 Buckingham Palace Road, London, SW1W 9SZ, United Kingdom. Electronic address: nasir.hussain@mhra.gsi.gov.uk","institution_ids":["https://openalex.org/I4405282191"]},{"raw_affiliation_string":"Medicines and Healthcare Products Regulatory Agency, Paediatric Unit, Special Populations Group, Vigilance and Risk Management of Medicines Division, 151 Buckingham Palace Road, London, SW1W 9SZ, United Kingdom","institution_ids":["https://openalex.org/I4405282191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101927551"],"corresponding_institution_ids":["https://openalex.org/I4405282191"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.2039,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.20454545,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"514","issue":"1","first_page":"15","last_page":"23"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.2240000069141388,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.14990000426769257,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.7210000157356262},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.7269999980926514},{"id":"https://openalex.org/keywords/m-cells","display_name":"M cells","score":0.7879999876022339},{"id":"https://openalex.org/keywords/peyer-s-patches","display_name":"Peyer's patches","score":0.9900000095367432},{"id":"https://openalex.org/keywords/intestinal-epithelium","display_name":"intestinal epithelium","score":0.8809999823570251},{"id":"https://openalex.org/keywords/regulatory-affairs","display_name":"regulatory affairs","score":0.5360000133514404},{"id":"https://openalex.org/keywords/common-technical-document","display_name":"Common Technical Document","score":0.7960000038146973},{"id":"https://openalex.org/keywords/ligands","display_name":"ligands","score":0.7799999713897705},{"id":"https://openalex.org/keywords/gastrointestinal-absorption","display_name":"gastrointestinal absorption","score":0.4659999907016754},{"id":"https://openalex.org/keywords/risk-assessment","display_name":"risk assessment","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.657655656337738},{"id":"https://openalex.org/C2781077229","wikidata":"https://www.wikidata.org/wiki/Q509615","display_name":"Intestinal epithelium","level":3,"score":0.6565864682197571},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5194472670555115},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.5006637573242188},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.46263402700424194},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3864714801311493},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38503342866897583},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.36974436044692993},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36862143874168396},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3363698124885559},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3164396286010742},{"id":"https://openalex.org/C529295009","wikidata":"https://www.wikidata.org/wiki/Q41301","display_name":"Epithelium","level":2,"score":0.30389195680618286},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.1974944770336151},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1565696895122528},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11974126100540161}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010581","descriptor_name":"Peyer's Patches","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ijpharm.2016.07.053","doi":"https://doi.org/10.1016/j.ijpharm.2016.07.053","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2016.07.053","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:27863658","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27863658","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320286","display_name":"University College London","ror":"https://ror.org/02jx3x895"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W25951409","https://openalex.org/W999655184","https://openalex.org/W1424782268","https://openalex.org/W1489955178","https://openalex.org/W1570333796","https://openalex.org/W1968291110","https://openalex.org/W1973426656","https://openalex.org/W1979665070","https://openalex.org/W1981256948","https://openalex.org/W1982619942","https://openalex.org/W1982938211","https://openalex.org/W1985274587","https://openalex.org/W1985305655","https://openalex.org/W1987777080","https://openalex.org/W1990503566","https://openalex.org/W1998162097","https://openalex.org/W2009111876","https://openalex.org/W2011778539","https://openalex.org/W2016388804","https://openalex.org/W2016614268","https://openalex.org/W2045802581","https://openalex.org/W2054523582","https://openalex.org/W2065857285","https://openalex.org/W2071284741","https://openalex.org/W2076597719","https://openalex.org/W2080421302","https://openalex.org/W2089302309","https://openalex.org/W2090530492","https://openalex.org/W2097863979","https://openalex.org/W2101648469","https://openalex.org/W2109325879","https://openalex.org/W2110903571","https://openalex.org/W2121216947","https://openalex.org/W2121496050","https://openalex.org/W2125045526","https://openalex.org/W2136761361","https://openalex.org/W2138685564","https://openalex.org/W2157873907","https://openalex.org/W2167878693","https://openalex.org/W2170979367","https://openalex.org/W2279781873","https://openalex.org/W2296698157","https://openalex.org/W2301007441","https://openalex.org/W2346141601","https://openalex.org/W2764050180","https://openalex.org/W4251960546"],"related_works":["https://openalex.org/W4382068679","https://openalex.org/W7010597409","https://openalex.org/W7125264513","https://openalex.org/W2406588140","https://openalex.org/W4403967399","https://openalex.org/W4399913117","https://openalex.org/W2126462892","https://openalex.org/W2040210681","https://openalex.org/W3065185430","https://openalex.org/W3047195650"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2552801722","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-11-30T00:00:00"}
